10.1002/ptr.6171 4 AdelusiO
Waldner, R., Laschan, C., Lohninger, A., Gessner, M., Tuchler, H., Huemer, M., Spiegel, W., and Karlic, H
Three of the five studies reported a significant reduction in cardiovascular events, particularly in groups with DM2 and high cardiovascular risk
What Clinical Research Says About Semaglutide and Tirzepatide Separating the underlying medication research from any individual platform's marketing matters here
Patients should be aware that food supplements are not subject to the same rigorous regulatory approval process as medicines, and efficacy claims may not be supported by robust clinical evidence
Expert Review of Molecular Diagnostics, 19(9), 797-807